AU Patent

AU2017204852B2 — Dual Platform System for the Delivery of Nitric Oxide

Assigned to Vero Biotech Inc · Expires 2019-06-13 · 7y expired

What this patent protects

A system for the delivery of nitric oxide can include a first platform including a first source of nitric oxide, a second platform including a second source of a nitric oxide, a delivery line coupled to the first platform and the second platform, and a controller 5 configured to …

USPTO Abstract

A system for the delivery of nitric oxide can include a first platform including a first source of nitric oxide, a second platform including a second source of a nitric oxide, a delivery line coupled to the first platform and the second platform, and a controller 5 configured to operate the first platform and the second platform simultaneously. A method of delivering nitric oxide can include communicating a first gas including nitric oxide through a first platform to a delivery line, communicating a second gas including nitric oxide through a second platform to the delivery line, and delivering the first gas and the second gas to a mammal via a delivery line. wj C:) 00 CD o -~ S-- to -& 4-j) - u i N0 to 0 C -w - -J - ) V) C a) x 7J 0 0 (V 4 a) Wa)14 c z w o 0) 00_ 0 =)00 LI). wnw-C -- 0 oo

Drugs covered by this patent

Patent Metadata

Patent number
AU2017204852B2
Jurisdiction
AU
Classification
—
Expires
2019-06-13
Drug substance claim
No
Drug product claim
No
Assignee
Vero Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.